Here are five things to know.
- The medical device tax entails a 2.3 percent excise tax on the sale of certain medical devices, payable by the manufacturer or importer of the device. The tax was imposed in 2013 as a funding mechanism for the ACA.
- Devicemakers have long opposed the tax, arguing it hurts innovation and unfairly burdens smaller device manufacturers.
- In 2015, Congress temporarily suspended the tax on the sale of nonretail medical devices like pacemakers, heart valves and artificial hips.
- The Senate bill would permanently repeal the tax before it takes effect again in 2018.
- The American Healthcare Act, passed in the House last month, also called for a repeal of the tax.
More articles on supply chain:
Drug manufacturer, distributor shut down for producing unapproved medications
Sanofi CEO on SCOTUS’ biologics ruling: 3 takeaways
Whole Foods acquisition could move Amazon closer to pharmacies
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
